机构地区:[1]中山大学附属第一医院内分泌科,广州510080
出 处:《中华糖尿病杂志》2018年第8期515-520,共6页CHINESE JOURNAL OF DIABETES MELLITUS
基 金:中山大学临床医学研究5010计划项目
摘 要:目的探讨微小核糖核酸miR-766在不同葡萄糖浓度培养的心肌细胞中的表达水平,明确其对心肌细胞凋亡的影响及相关分子机制。方法在不同葡萄糖浓度条件下(正常糖5mmol/L、高糖15、25及35mmol/L)培养的心肌细胞中,采用实时荧光定量聚合酶链式反应(PCR)检测miR-766的表达差异,以流式细胞术检测各组心肌细胞凋亡情况,Western blot法检测各组环腺苷酸活化交换蛋白l(Epac-1)、Bax蛋白、半胱氨酸天冬氨酸特异性蛋白酶-3(caspase-3)活化片段蛋白表达水平。采用生物信息学预测miR-766的靶基因,并进一步采用双荧光素酶报告基因法进行验证。组间数据比较采用t检验。结果与5mmol/L相比,miR-766在15、25及35mmol/L组的心肌细胞中表达上调(3.40±0.38,4.61±0.34,6.17±0.42比0.97±0.04,t=11.13l-21.493,P〈0.05),而转染miR-766抑制剂后,细胞的凋亡率明显降低[(16.43±0.31)%比(26.45±0-31)%,t=39.566,P〈0.05];Western blot结果表明,在人心肌细胞中miR-766高表达者Epac-1的蛋白表达减少(0.48±0.07比1.00±O.12,t=6.695,P〈0.05),而抑制miR-766的表达后Epac-1的表达增加(1.23±0.12比0.70±0.10,t=5.884,P〈0.05);荧光素酶报告基因结果表明,miR-766模拟物或抑制剂与Epae-1基因3'-非翻译区野生型报告基因共转染时,报告基因荧光素酶活性明显变化(3.22±0.07比5.01±0.96,6.98±0.61比5.01±O.96,t=-3.239~-3.008,P〈0.05);在高糖培养条件下抑制miR-766表达能够部分拮抗高糖对Epac-1蛋白表达的抑制作用(0.80±0.05比0.53±0.05,t=6.810,P〈0.05);在miR-766模拟物处理的H9e2细胞中回补Epae-1,easpase-3活化片段蛋白的表达则明显降低(O.67±0.07比1.07±0.12,t=-5.050,P〈0.05)。结论在高糖培养的心肌细胞中高表达的miR-7Objective To investigate the expression levels and functional role of microRNA 766 (miR-766) in cardiomyocytes treated with high glucose conditions. Method Cardiomyocytes were cultured with different concentrations of glucose levels at 5.0 mmol/L (Controls), 15, 25 or 35 retool/L, respectively. The expression of miR-766 was detected by real-time PCR, apoptosis was detected by flow cytometry, and the expressions of exchange protein directly activated by cyclic adenylic acid isoform 1 (Epac-1), Bax and cleaved cysteinyl aspartate specific proteinase-3 (caspase-3) were determined by Western blot. The target gene of miR-766 calculated by bioinformatics was further determined by using dual luciferase system. T test was used for comparison between groups. Results Compared with the controls, the expressions of miR-766 were significantly upregulated in different high glucose (HG)-stimulated eardiomyocytes (3.40 ± 0.38, 4.61±0.34, 6.17 ±0.42 vs 0.97±0.04, t=11.131-21.493, all P〈0.05). Inhibition of miR-766 in cardiomyocytes treated with HG resulted in reduced apoptosis [(16.43 ± 0.31)% vs (26.45 ± 0.31)% ,t=-39.566, P〈0.05]. Overexpression of miR-766 decreased the protein levels of Epac-1 (0.48±0.07 vs 1.00± 0.12, t=-6.695, P〈0.05), and inhibition of miR-766 increased the protein levels of Epac-1 (1.23±0.12 vs 0.70±0.10, t=5.884, P〈0.05). Luciferase reporter assays showed that overexpression of miR-766 significantly decreased the luciferase activity of wild-type reporter, and inhibition of miR-766 significantly increased the luciferase activity of wild-type reporter (3.22 ± 0.07 vs 5.01 ± 0.96; 6.98 ± 0.61 vs 5.01 ± 0.96, t=-3.239- -3.008, P〈0.05). Moreover, transfection of miR-766 inhibitor could partly reverse the suppression of Epac-1 by HG in H9c2 cells (0.80±0.05 vs 0.53±0.05, t=6.810, P〈0.05). Restoration of Epac-1 in miR-766-treated H9c2 cells reversed the effects of miR-766 on cleaved caspase-3 expression (0.67 ± 0.07 vs 1.07 ± 0.12, t
关 键 词:糖尿病心肌病 细胞凋亡 微RNAS miR-766 环腺苷酸活化交换蛋白1
分 类 号:R542.2[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...